Page 30 - Perfect Diary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Analysts’ downgrades for Tuesday, May 31st: Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable […]

They’ve got money to burn, eschew foreign labels, and are driven by a swelling sense of nationalism that can ensnare even the biggest global brands.

They’ve got money to burn, eschew foreign labels, and are driven by a swelling sense of nationalism that can ensnare even the biggest global brands.

BEIJING (Bloomberg): They’ve got money to burn, eschew foreign labels, and are driven by a swelling sense of nationalism that can ensnare even the biggest global brands.

Yatsen (NYSE:YSG – Get Rating) posted its earnings results on Tuesday. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.17), Fidelity Earnings reports. Yatsen had a negative return on equity of 19.62% and a negative net margin of 26.42%. During the same quarter last year, the company earned […]